In conclusion, this study validates the BGA’s reliability compared to laboratory measurements and offers a clinically viable tool for Hb estimation and anemia management in hemodialysis patients, if the total error of ~0.8–0.9 g/dL is clinically acceptable. This evidence concerns the gene GSTM1 and anemia.